Skip to main content
ACS Omega logoLink to ACS Omega
. 2020 May 29;5(22):13136–13147. doi: 10.1021/acsomega.0c01150

Catalyst- and Additive-Free Method for the Synthesis of 2-Substituted Benzothiazoles from Aromatic Amines, Aliphatic Amines, and Elemental Sulfur

Xiaoming Zhu †,, Fengru Zhou , Yuan Yang , Guobo Deng †,*, Yun Liang †,*
PMCID: PMC7288589  PMID: 32548500

Abstract

graphic file with name ao0c01150_0011.jpg

Under catalyst- and additive-free conditions, a novel, convenient, environmentally friendly method was developed for the synthesis of 2-substituted benzothiazoles via the three-component one pot reaction from aromatic amines, aliphatic amines, and elemental sulfur. The reaction achieves double C–S and one C–N bond formations via cleavage of two C–N bonds and multiple C–H bonds. Furthermore, the mechanism research shows that DMSO acts as an oxidant in the cyclization reaction.

Introduction

Benzothiazoles are highly important structural scaffolds for a variety of compounds that prevalently exist in functional molecules applied in biology, pharmacy, and material science.1 As one of the most important components, 2-substituted benzothiazoles exhibit good pharmaceutical activity, which appear as a core skeleton in antimicrobial, antitumor, anticonvulsant, antituberculosis, calcium-channel antagonist, and neuroprotective agents.2 Therefore, considerable interest has been inclined toward the development of efficient methods for the synthesis of 2-substituted benzothiazoles.3

Traditional methods for synthesizing 2-subsituted benzothiazoles involve two kinds of approaches. The first one is transition-metal-catalyzed intramolecular cyclization of thiobenzanilides.4 The second kind of methods involve the condensation of 2-aminobenzenethiol with alcohols, carboxylic acids, aldehydes, aryl ketones, arylacetylenes, or styrenes.5 In addition, the C–H functionalization of the 2-position of benzothiazoles with aryl halides, arylsilanes, aromatic carboxylic acids, arylboronic acids, and triflates has become a useful strategy for the construction of 2-arylbenzothiazoles.6 However, these approaches still have some shortcomings, such as employing prefunctionalized substrates, stoichiometric toxic oxidants, expensive transition-metal catalysts, etc. Recently, the methods of synthesizing 2-substituted benzothiazoles by three-component reaction are very popular.7 The advantages of the three-component reaction involve a simple operation and using cheap and easily available elemental sulfur as the sulfur source. Among them, the classic methods for the synthesis of 2-substituted benzothiazoles mainly include the transition metal-catalyzed intramolecular cyclization of 2-haloanilides8 and condensation of o-halonitrobenzenes9 with other reagents under metal-free conditions. These methods are very effective for the construction of 2-substituted benzothiazoles. However, these reactions are still limited by the use of transition-metal catalysts and halogenated substrates. Therefore, it is highly desirable to exploit the novel strategies to synthesize 2-substituted benzothiazoles from readily available raw materials under mild and simple reaction conditions. Amines are one of the most useful synthons in organic synthesis that widely exist in nature with stable chemical properties and are commercially available. It would be a very good strategy to overcome these deficiencies by using amine compounds instead of halogenated compounds as reaction substrates. Recently, Deng and co-workers reported some novel methods of synthesizing 2-substituted benzothiazoles from amines, elemental sulfur, and benzaldehydes10 (Scheme 1a) or styrenes11 (Scheme 1b). In addition, Chen and co-workers developed an iodine-catalyzed one-pot reaction of aromatic amines, acetophenones, and sulfur powder for the synthesis of 2-aryl benzothiazoles12 (Scheme 1c). In order to have the prospect of industrialization, it is still urgent to find simpler and more economical ways to synthesize 2-substituted benzothiazoles.

Scheme 1. Synthesis of 2-Substituted Benzothiazoles from Amine and Elemental Sulfur under Metal-Free Conditions.

Scheme 1

Within our continuous program on the development of a new approach for the construction of 2-substituted benzothiazoles by using sulfide or sulfur powder as a sulfur source,13 we herein report a three-component reaction for the construction of 2-substituted benzothiazoles from aromatic amines, aliphatic amines, and elemental sulfur under catalyst-free and additive-free conditions.

Results and Discussion

We began our study by examining the reaction of 2-naphthylamine (1a), benzylamine (2a), and sulfur powder in DMSO at 140 °C under a nitrogen atmosphere (Table 1). To our delight, the desired product 3a was obtained in an 83% yield (entry 1). Then, the solvents including DMF, NMP, MeCN, and DMAC were screened (entries 2–5). The results indicated that the best solvent for this reaction was DMSO. Subsequently, the amount of S8 and 2a was evaluated (entries 6–10). The results showed that 2 equiv of 2a and 3 equiv of S8 are the most suitable doses, giving the corresponding product in a 90% yield (entry 8). Finally, the temperature screening indicated that lower temperature is not suitable for this reaction and 140 °C is the most suitable temperature (entries 8 and 11). Thus, the optimal condition of this three-component reaction is as follows: 1a (0.2 mmol), 2a (0.4 mmol), and S8 (0.075 mmol) in DMSO (2 mL) under N2 at 140 °C for 22 h.

Table 1. Optimization of the Reaction Conditionsa.

graphic file with name ao0c01150_0004.jpg

entry S (equiv) solvent yield (%)b
1 3 DMSO 83
2 3 DMF 14
3 3 NMP 38
4 3 CH3CN 27
5 3 DMAC 28
6 4 DMSO 63
7 2 DMSO 64
8c 3 DMSO 90
9d 3 DMSO 65
10e 3 DMSO 87
11f 3 DMSO 64
a

Reaction conditions: 1a (0.2 mmol), 2a (0.3 mmol), and solvent (2 mL) under a N2 atmosphere in a sealed Schlenk tube at 140 °C for 22 h.

b

Isolated yields.

c

2a (2 equiv).

d

2a (1.2 equiv)

e

2a (3 equiv).

f

120 °C.

With the optimized reaction conditions in hand, we evaluated the scope and generality of this three-component reaction. Initially, the various monosubstituted benzylamines were screened (Table 2). The results demonstrated that both the electron-rich and electron-deficient group-substituted benzylamines could smoothly be transformed into the desired products. Meanwhile, substituents at different positions of the benzyl (para, meta, and ortho positions) could all achieve moderate to good yields, and the steric hindrance effect is not obvious (3a3u). To our delight, the substrate bearing active amino at para, meta, and ortho positions of the benzyl formed 3g, 3m, and 3r in 70, 73, and 42 yields, respectively. As expected, multisubstituted benzylamines could also efficiently be converted into the corresponding products in medium to good yields (3v3z). The results showed that the electron-donating-group substrates displayed higher reactivity than that of the electron-withdrawing-group substrates. Notably, the reaction was compatible with some heterocyclic amines such as pyridinylmethanamines and thiophen-2-ylmethanamine, affording the corresponding products 3aa3ad in 80, 61, 32, 62, and 16% yields, respectively. Moreover, naphthalen-1-amine could be successfully converted into polycyclic product 3ae in an 80% yield. Finally, the substrate 6-bromonaphthalen-2-amine provided 7-bromo-2-phenylnaphtho[2,1-d]thiazole 3ba in a 76% yield.

Table 2. Substrate Scope with Respect to Benzylaminesa,b.

graphic file with name ao0c01150_0005.jpg

graphic file with name ao0c01150_0006.jpg

a

1 (0.2 mmol), 2 (0.4 mmol), S8 (0.075 mmol), and DMS0 (2 mL) under a N2 atmosphere in a sealed Schlenk tube at 140 °C for 22 h.

b

Isolated yields.

To further examine the scope and limitations of the reaction, various anilines were tested instead of naphthalenamines (Table 3). However, only electron-donating groups such as methyl, methoxyl, phenoxy, N,N-dimethylamino, and acetyl amino-substituted anilines could smoothly be transformed into the target products in moderate to good yields (4a4i). These results indicated that the reaction might undergo a process of an electrophilic attack.

Table 3. Substrate Scope of Anilinesa,b.

graphic file with name ao0c01150_0007.jpg

graphic file with name ao0c01150_0008.jpg

a

1(0.2 mmol), 2a (0.4 mmol), S8 (0.075 mmol), and DMS0 (2 mL) under a N2 atmosphere in a sealed Schlenk tube at 140 °C for 22 h,

b

Isolated yields.

To further expand the substrate scope, we next examined the effects of the different substitutes of some other aliphatic amines (Table 4). Various secondary amides (2af2ai) and tertiary amines (2aj2ak) were successfully converted into the corresponding product 3a in 60–99% yields under the standard reaction conditions. These results indicated that the substituents from N-substituted benzylamine did not remarkably affect the reaction. To our delight, the aliphatic amine such as triethylamine and isobutylamine afforded the desired products (3ak and 3al) in 28 and 19% yields, respectively. However, we also tried some other alkyl-substituted substrates such as diethylamine (2am) or phenylethylamine (2an); the reaction did not get the target product under the standard conditions.

Table 4. Substrate Scope of Benzylamines and Aliphatic Aminesa,b.

graphic file with name ao0c01150_0009.jpg

graphic file with name ao0c01150_0010.jpg

a

1a (0.2 mmol), 2 (2.0 equiv), S8 (0.075 mmol), and DMSO (2 mL) under a N2 atmosphere in a sealed Schlenk tube at 140 °C for 22 h.

b

Isolated yields.

A series of control experiments were performed to investigate the possible reaction mechanism (Scheme 2). First, in order to capture the reaction intermediate, under the standard reaction conditions, when the reaction of 2-naphthylamine (1a), benzylamine (2a), and sulfur powder was performed in 2 h, the imine (A and D), benzaldehyde (B), N-benzylthiobenzamide (C), and benzonitrile (E) could be detected from the reaction mixture by GC–MS analysis (Scheme 2a). Subsequently, under standard reaction conditions, C or E could not transfer into 2-phenylnaphtho[2,1-d]thiazole (Scheme 2b,c). However, the reaction of A or B with 2-naphthylamine and sulfur powder generated the desired product 3a in 97 or 69% yields, respectively, which indicated that this reaction probably involves two different pathways (Scheme 2d,e). In addition, the reaction of D and sulfur powder could smoothly transform into the target product 3a (Scheme 2f). The result indicated that A, B, and D may be the intermediates of the reaction. In addition, in the absence of 2-naphthylamine under same reaction conditions, the intermediates A and B were detected from the reaction mixture by GC–MS analysis (Scheme 2g). Furthermore, when DMSO was replaced by methyl phenyl sulfoxide, benzothiazolethione 2a could be isolated in a 65% yield, and the methyl(phenyl)sulfide was detected via GC–MS analysis (Scheme 2h). These results reveal that DMSO could be performed as an oxidant in this reaction. When elemental sulfur was removed from the reaction, the reaction could not proceed (Scheme 2i). In addition, the corresponding product 3a could be obtained under the conditions of DMF, NMP, CH3CN, or DMAC instead of DMSO (Table 1, entry 2–5). These results indicated that the sulfur source of the product came from S8. Finally, in order to study the practicability of the reaction, we performed a 5 mmol-scale magnification experiment and obtained the desired product in an 80% yield (Scheme 2j).

Scheme 2. Controlled Experiments.

Scheme 2

Base on the experimental results and previous reports,13c,14 a possible reaction mechanism has been outlined (Scheme 3). First, under the oxidation of DMSO, benzylamine 2a is converted into imine intermediate A, which may undergo two reaction pathways to form the intermediate D. In route a, D is formed by a nucleophilic addition/elimination reaction of 2-naphthylamine 1a with A. In route b, A is converted to intermediate B by hydrolysis, and then B reacts with 2-naphthylamine to generate D. Subsequently, an electrophilic attack of elemental sulfur (Sn) to D gives F, which releases elemental sulfur (Sn–1) and a hydrogen proton to obtain sulfurated imine G. Finally, intermolecular nucleophilic cyclization of intermediate G generates thiazoline H and then proceeds through oxidative aromatization to give the desired product 2-phenylnaphtho[2,1-d]thiazole 3a.

Scheme 3. Possible Mechanism.

Scheme 3

Conclusions

In summary, we have disclosed a novel, convenient, environmentally friendly method for synthesis of 2-substituted benzothiazoles and 2-substituted naphthothiazoles from aromatic amines, aliphatic amines, and sulfur powder under catalyst- and additive-free conditions. In this reaction, DMSO served as an oxidant and solvent. This transformation is easy to conduct under mild oxidative conditions to generate double C–S and one C–N bond formations in a cascade sequence and features a broad substrate scope, good functional group tolerance, and an environmentally benign character. Further studies of this method will focus on the detailed mechanism and applications in organic synthesis.

Experimental Section

General Information

1H, 13C, and 19F NMR spectra were recorded on a Bruker Avance-500 instrument (500 MHz for 1H, 125 MHz for 13C, and 125 MHz for 19F) at room temperature, unless otherwise noted. High-resolution mass spectra (HRMS) were recorded on a Thermo Scientific LTQ Orbitrap XL mass spectrometer using ESI (electrospray ionization). Low-resolution mass spectra (LRMS) data were measured on GCMS-QP2010 Ultra. Reactions were monitored by thin-layer chromatography. Column chromatography was performed on silica gel (200–300 mesh) using petroleum ether (PE)/ethyl acetate (EA). Analytical-grade solvents and commercially available reagents were purchased from commercial sources and used directly without further purification unless otherwise stated.

Typical Experimental Procedure for the Synthesis of 3 or 4

The sealed Schlenk tube was charged with 2-naphthylamines or anilines (1, 0.2 mmol), aliphatic amines (2, 0.4 mmol), S8 (0.075 mmol), and DMSO (2 mL). Then, under the protection of a nitrogen atmosphere, the mixture was stirred at 140 °C for 22 h. After the completion of the reaction (monitored by TLC), the reaction mixture was cooled to room temperature, quenched by water, and extracted with ethyl acetate. The combined organic layer was dried over Na2SO4 and concentrated in vacuum, and the resulting residue was purified by silica gel column chromatography (petroleum ether/ethyl acetate) to afford the pure product 3 or 4.

Typical Experimental Procedure for the Scale Magnification Experiments

The sealed Schlenk tube was charged with 2-naphthylamine 1a (5 mmol, 0.7180 g), benzylamine 2a (10 mmol, 1.0720), S8 (1.875 mmol, 0.4865 g), and DMSO (10 mL). Then, under the protection of a nitrogen atmosphere, the mixture was stirred at 140 °C for 22 h. After the completion of the reaction (monitored by TLC), the reaction mixture was cooled to room temperature, quenched by water, and extracted with ethyl acetate. The combined organic layer was dried over Na2SO4 and concentrated in vacuum, and the resulting residue was purified by silica gel column chromatography (petroleum ether/ethyl acetate) to afford the pure product (3a) in 80% yields.

2-Phenylnaphtho[2,1-d]thiazole (3a)13

Prepared according to the typical procedure as a light yellow solid (48 mg, 90%). mp: 109–110 °C. 1H NMR (CDCl3, 500 MHz) δ 8.15–8.13 (m, 2H), 8.11 (d, J = 8.5 Hz, 1H), 8.01 (d, J = 8.0 Hz, 1H), 7.95 (d, J = 8.0 Hz, 1H), 7.87 (d, J = 9.0 Hz, 1H), 7.58 (t, J = 7.0 Hz, 1H), 7.55–7.49 (m, 4H). 13C NMR (CDCl3, 125 MHz) δ 167.08, 152.11, 133.57, 132.11, 130.94, 130.65, 128.98, 128.89, 127.97, 127.35, 127.23, 126.92, 125.91, 125.08, 121.61.

2-(p-Tolyl)naphtho[2,1-d]thiazole (3b)13

Prepared according to the typical procedure as a yellow solid (44 mg, 79%). mp: 137–139 °C. 1H NMR (CDCl3, 500 MHz) δ 8.09 (d, J = 9.0 Hz, 1H), 8.04–8.00 (m, 3H), 7.95 (d, J = 8.0 Hz, 1H), 7.86 (d, J = 9.0 Hz, 1H), 7.59 (td, J = 8.0 Hz, J = 1.0 Hz, 1H), 7.53 (td, J = 8.0 Hz, J = 1.0 Hz, 1H), 7.30 (d, J = 8.0 Hz, 2H), 2.43 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ 167.35, 152.19, 141.09, 131.93, 131.00, 130.95, 129.70, 128.92, 128.07, 127.28, 127.20, 126.91, 125.81, 125.10, 121.60, 21.47.

2-(4-(tert-Butyl)phenyl)naphtho[2,1-d]thiazole (3c)10

Prepared according to the typical procedure as a yellow solid (65 mg, 95%). mp: 120–122 °C. 1H NMR (CDCl3, 500 MHz) δ 8.11 (d, J = 9.0 Hz, 1H), 8.08 (d, J = 8.5 Hz, 2H), 8.03 (d, J = 8.0 Hz, 1H), 7.96 (d, J = 8.0 Hz, 1H), 7.87 (d, J = 8.5 Hz, 1H), 7.60 (t, J = 7.0 Hz, 1H), 7.55–7.52 (m, 3H), 1.39 (s, 9H). 13C NMR (CDCl3, 125 MHz) δ 167.26, 154.25, 152.24, 131.97, 130.97, 128.94, 128.09, 127.28, 127.10, 126.92, 126.00, 125.84, 125.13, 121.65, 34.94, 31.17.

2-(4-(Trifluoromethoxy)phenyl)naphtho[2,1-d]thiazole (3d)13

Prepared according to the typical procedure as a yellow solid (67 mg, 95%). mp: 141–143 °C. 1H NMR (CDCl3, 500 MHz) δ 8.16–8.14 (m, 2H), 8.08 (d, J = 7.5 Hz, 1H), 8.01 (d, J = 8.0 Hz, 1H), 7.96 (d, J = 8.0 Hz, 1H), 7.87 (d, J = 8.5 Hz, 1H), 7.61–7.58 (m, 1H), 7.56–7.54 (m, 1H), 7.34 (d, J = 8.5 Hz, 2H). 13C NMR (CDCl3, 125 MHz) δ 165.26, 152.20, 150.83, 132.38, 132.26, 131.13, 129.01, 128.79, 128.00, 127.64, 127.12, 126.18, 125.14, 121.67, 121.25, 120.40 (q, J = 256.50). 19F NMR (CDCl3, 470 MHz) δ −57.63.

2-(4-Methoxyphenyl)naphtho[2,1-d]thiazole (3e)13

Prepared according to the typical procedure as a yellow solid (39 mg, 65%). mp: 106–108 °C. 1H NMR (CDCl3, 500 MHz) δ 8.08–8.06 (m, 3H), 7.99 (d, J = 8.0 Hz, 1H), 7.94 (d, J = 8.0 Hz, 1H), 7.85 (d, J = 9.0 Hz, 1H), 7.58 (td, J = 8.0 Hz, J = 1.0 Hz, 1H), 7.52 (td, J = 8.0 Hz, J = 1.0 Hz, 1H), 7.00 (d, J = 8.5 Hz, 2H), 2.87 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ 167.05, 161.72, 152.16, 131.68, 130.87, 128.92, 128.83, 128.07, 127.24, 126.89, 126.47, 125.71, 125.04, 121.47, 114.37, 55.40.

2-(4-Isopropylphenyl)naphtho[2,1-d]thiazole (3f)

Prepared according to the typical procedure as an orange-yellow solid (36 mg, 61%). mp: 95–97 °C. 1H NMR (CDCl3, 500 MHz) δ 8.11 (d, J = 9.0 Hz, 1H), 8.08 (d, J = 8.0 Hz, 2H), 8.02 (d, J = 8.0 Hz, 1H), 7.95 (d, J = 8.0 Hz, 1H), 7.87 (d, J = 9.0 Hz, 1H), 7.59 (td, J = 8.0 Hz, J = 1.0 Hz, 1H), 7.53 (td, J = 8.0 Hz, J = 1.0 Hz, 1H), 7.37 (d, J = 8.0 Hz, 2H), 3.02–2.97 (m, 1H), 1.32 (d, J = 6.5 Hz, 6H). 13C NMR (CDCl3, 125 MHz) δ 167.31, 152.20, 151.95, 131.93, 131.33, 130.92, 128.91, 128.05, 127.33, 127.25, 127.11, 126.89, 125.80, 125.09, 121.61, 34.08, 23.75. HRMS (ESI) m/z calcd for C20H18NS+ (M + H)+: 304.1155, found: 304.1154.

4-(Naphtho[2,1-d]thiazol-2-yl)aniline (3g)

Prepared according to the typical procedure as a brown solid (38 mg, 70%). mp: 198–200 °C. 1H NMR (CDCl3, 500 MHz) δ 8.05 (d, J = 8.5 Hz, 1H), 8.00 (d, J = 8.0 Hz, 1H), 7.96–7.94 (m, 3H), 7.85 (d, J = 9.0 Hz, 1H), 7.58 (t, J = 7.5 Hz, 1H), 7.51 (t, J = 7.5 Hz, 1H), 6.75 (d, J = 8.5 Hz, 2H), 4.00 (s, 2H). 13C NMR (CDCl3, 125 MHz) δ 167.81, 152.25, 149.02, 131.27, 130.78, 128.92, 128.88, 128.13, 127.08, 126.82, 125.51, 125.04, 124.09, 121.40, 114.84. HRMS (ESI) m/z calcd for C17H13N2S+ (M + H)+: 277.0794, found: 277.0792.

2-(4-Fluorophenyl)naphtho[2,1-d]thiazole (3h)

Prepared according to the typical procedure as a yellow solid (35 mg, 62%). mp: 139–142 °C. 1H NMR (CDCl3, 500 MHz) δ 8.13–8.10 (m, 2H), 8.08 (d, J = 9.0 Hz, 1H), 8.00 (d, J = 8.0 Hz, 1H), 7.96 (d, J = 8.0 Hz, 1H), 7.87 (d, J = 8.5 Hz, 1H), 7.61–7.58 (m, 1H), 7.54 (t, J = 7.5 Hz, 1H), 7.19 (t, J = 8.5 Hz, 2H). 13C NMR (CDCl3, 125 MHz) δ 165.83, 164.28 (d, J = 250.1 Hz), 152.15, 132.15, 131.04, 130.01 (d, J = 3.3 Hz), 129.23 (d, J = 8.8 Hz), 128.98, 128.02, 127.50, 127.05, 126.02, 125.09, 121.59, 116.16 (d, J = 21.9 Hz). 19F NMR (CDCl3, 470 MHz) δ −109.22. HRMS (ESI) m/z calcd for C17H11FNS+ (M + H)+: 280.0591, found: 280.0593.

2-(4-Chlorophenyl)naphtho[2,1-d]thiazole (3i)10

Prepared according to the typical procedure as a yellow solid (37 mg, 63%). mp: 181–183 °C. 1H NMR (CDCl3, 500 MHz) δ 8.08–8.04 (m, 3H), 8.00 (d, J = 8.0 Hz, 1H), 7.96 (d, J = 7.5 Hz, 1H), 7.87 (d, J = 9.0 Hz, 1H), 7.62–7.59 (m, 1H), 7.57–7.54 (m, 1H), 7.47 (d, J = 9.0 Hz, 2H). 13C NMR (CDCl3, 125 MHz) δ 165.67, 152.12, 136.70, 132.23, 132.11, 131.06, 129.26, 128.98, 128.41, 127.96, 127.59, 127.09, 126.12, 125.11, 121.59.

2-(4-Bromophenyl)naphtho[2,1-d]thiazole (3j)10

Prepared according to the typical procedure as a yellow solid (32 mg, 47%). mp: 197–199 °C. 1H NMR (CDCl3, 500 MHz) δ 8.08 (d, J = 8.5 Hz, 1H), 8.03–7.99 (m, 3H), 7.97 (d, J = 8.0 Hz, 1H), 7.88 (d, J = 9.0 Hz, 1H), 7.65–7.63 (m, 2H), 7.61–7.59 (m, 1H), 7.56 (td, J = 8.0 Hz, J = 1.5 Hz, 1H). 13C NMR (CDCl3, 125 MHz) δ 165.77, 152.22, 132.63, 132.26, 131.14, 129.03, 128.66, 128.03, 127.64, 127.13, 126.17, 125.16, 125.12, 121.66.

2-(4-(Trifluoromethyl)phenyl)naphtho[2,1-d]thiazole (3k)13

Prepared according to the typical procedure as a yellow solid (45 mg, 67%). mp: 173–175 °C. 1H NMR (CDCl3, 500 MHz) δ 8.16 (d, J = 8.0 Hz, 2H), 8.06 (d, J = 9.0 Hz, 1H), 7.96 (d, J = 8.0 Hz, 1H), 7.92 (d, J = 8.0 Hz, 1H), 7.84 (d, J = 9.0 Hz, 1H), 7.71 (d, J = 8.5 Hz, 2H), 7.59–7.52 (m, 2H). 13C NMR (CDCl3, 125 MHz) δ 164.91, 152.16, 136.71, 132.58, 132.08 (q, J = 32.63 Hz), 131.17, 128.98, 127.89, 127.74, 127.37, 127.14, 126.31, 125.94 (q, J = 3.88 Hz), 125.11, 122.22 (q, J = 270.75 Hz), 121.70. 19F NMR (CDCl3, 470 MHz) δ −62.78.

2-(m-Tolyl)naphtho[2,1-d]thiazole (3l)13

Prepared according to the typical procedure as a yellow solid (45 mg, 79%). mp: 102–104 °C. 1H NMR (CDCl3, 500 MHz) δ 8.11 (d, J = 8.5 Hz, 1H), 8.03–7.99 (m, 2H), 7.96 (d, J = 8.0 Hz, 1H), 7.92 (d, J = 7.5 Hz, 1H), 7.87 (d, J = 9.0 Hz, 1H), 7.59 (td, J = 7.0 Hz, J = 1.5 Hz, 1H), 7.54 (td, J = 8.0 Hz, J = 1.5 Hz, 1H), 7.40 (t, J = 8.0 Hz, 1H), 7.30 (d, J = 7.5 Hz, 1H), 2.47 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ 167.42, 152.16, 138.86, 133.56, 132.10, 131.54, 131.00, 128.94, 128.93, 128.07, 127.75, 127.35, 126.96, 125.91, 125.12, 124.59, 121.65, 21.35.

3-(Naphtho[2,1-d]thiazol-2-yl)aniline (3m)

Prepared according to the typical procedure as a yellow solid (41 mg, 73%). mp: 182–185 °C. 1H NMR (CDCl3, 500 MHz) δ 8.09 (d, J = 9.0 Hz, 1H), 8.01 (d, J = 8.0 Hz, 1H), 7.95 (d, J = 8.0 Hz, 1H), 7.86 (d, J = 9.0 Hz, 1H), 7.59 (t, J = 7.5 Hz, 1H), 7.55–7.48 (m, 3H), 7.28 (t, J = 8.0 Hz, 1H), 6.80 (dd, J = 7.5 Hz, J = 1.5 Hz, 1H), 3.68 (s, 2H). 13C NMR (CDCl3, 125 MHz) δ 167.50, 152.04, 147.00, 134.52, 132.08, 130.96, 129.96, 128.92, 128.03, 127.31, 126.94, 125.89, 125.10, 121.61, 117.82, 117.40, 113.14. HRMS (ESI) m/z calcd for C17H13N2S+ (M + H)+: 277.0794, found: 277.0792.

2-(3-Fluorophenyl)naphtho[2,1-d]thiazole (3n)10

Prepared according to the typical procedure as a yellow solid (45 mg, 81%). mp: 113–115 °C. 1H NMR (CDCl3, 500 MHz) δ 8.08 (d, J = 9.0 Hz, 1H), 8.00 (d, J = 8.0 Hz, 1H), 7.95 (d, J = 8.0 Hz, 1H), 7.88–7.85 (m, 3H), 7.60 (t, J = 7.5 Hz, 1H), 7.55 (t, J = 7.0 Hz, 1H), 7.48–7.44 (m, 1H), 7.18 (td, J = 8.0 Hz, J = 2.0 Hz, 1H). 13C NMR (CDCl3, 125 MHz) δ 165.44 (d, J = 3.00 Hz), 163.06 (d, J = 245.8 Hz), 152.10, 135.73 (d, J = 8.00 Hz), 132.37, 131.14, 130.60 (d, J = 8.1 Hz), 128.98, 127.98, 127.61, 127.09, 126.18, 125.13, 123.02 (d, J = 3.1 Hz), 121.70, 117.51 (d, J = 21.50 Hz), 114.03 (d, J = 23.5 Hz). 19F NMR (CDCl3, 470 MHz) δ −111.96.

2-(2-Bromophenyl)naphtho[2,1-d]thiazole (3o)10

Prepared according to the typical procedure as a yellow solid (52 mg, 75%). mp: 148–150 °C. 1H NMR (CDCl3, 500 MHz) δ 8.27 (t, J = 2.0 Hz, 1H), 8.05 (d, J = 8.5 Hz, 1H), 7.98–7.92 (m, 3H), 7.84 (d, J = 8.5 Hz, 1H), 7.58–7.51 (m, 3H), 7.32 (t, J = 8.0 Hz, 1H). 13C NMR (CDCl3, 125 MHz) δ 165.03, 152.01, 135.42, 133.39, 132.32, 131.07, 130.41, 129.90, 128.92, 127.88, 127.59, 127.04, 126.14, 125.77, 125.07, 123.14, 121.60.

2-(3-(Trifluoromethyl)phenyl)naphtho[2,1-d]thiazole (3p)

Prepared according to the typical procedure as a white solid (51 mg, 76%). mp: 133–135 °C. 1H NMR (CDCl3, 500 MHz) δ 8.41 (s, 1H), 8.26 (d, J = 7.5 Hz, 1H), 8.09 (d, J = 8.5 Hz, 1H), 8.01 (d, J = 8.5 Hz, 1H), 7.96 (d, J = 8.0 Hz, 1H), 7.88 (d, J = 9.0 Hz, 1H), 7.73 (d, J = 8.0 Hz, 1H), 7.63–7.59 (m, 2H), 7.56 (td, J = 8.0 Hz, J = 1.0 Hz, 1H). 13C NMR (CDCl3, 125 MHz) δ 165.07, 152.09, 134.38, 132.42, 131.60 (q, J = 32.6 Hz), 131.19, 130.35, 129.58, 129.01, 127.94, 127.77, 127.18, 127.05 (q, J = 3.8 Hz), 126.31, 125.13, 123.96 (q, J = 4.00 Hz), 123.77 (q, J = 270.88 Hz), 121.67. 19F NMR (CDCl3, 470 MHz) δ −62.70. HRMS (ESI) m/z calcd for C18H11F3NS+ (M + H)+: 330.0559, found: 330.0557.

2-(o-Tolyl)naphtho[2,1-d]thiazole (3q)13

Prepared according to the typical procedure as a white solid (49 mg, 87%). mp: 69–71 °C. 1H NMR (CDCl3, 500 MHz) δ 8.15 (d, J = 9.0 Hz, 1H), 8.06 (d, J = 8.0 Hz, 1H), 7.99 (d, J = 8.0 Hz, 1H), 7.90 (d, J = 9.0 Hz, 1H), 7.87 (d, J = 8.0 Hz, 1H), 7.61 (td, J = 7.0 Hz, J = 1.5 Hz, 1H), 7.56 (td, J = 8.0 Hz, J = 1.0 Hz, 1H), 7.42–7.33 (m, 3H), 2.73 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ 166.96, 151.77, 137.12, 133.08, 132.72, 131.55, 130.96, 130.51, 129.87, 128.94, 127.98, 127.19, 126.94, 126.13, 125.95, 125.26, 121.84, 21.48.

2-(Naphtho[2,1-d]thiazol-2-yl)aniline (3r)

Prepared according to the typical procedure as a yellow solid (24 mg, 42%). mp: 134–136 °C. 1H NMR (CDCl3, 500 MHz) δ 8.02–8.00 (m, 2H), 7.95 (d, J = 8.0 Hz, 1H), 7.84 (d, J = 9.0 Hz, 1H), 7.80 (d, J = 8.0 Hz, 1H), 7.59 (t, J = 7.0 Hz, 1H), 7.53 (t, J = 7.5 Hz, 1H), 7.24 (td, J = 8.0 Hz, J = 1.0 Hz, 1H), 6.82–6.77 (m, 2H), 6.40 (s, 2H). 13C NMR (CDCl3, 125 MHz) δ 168.43, 151.59, 146.46, 131.30, 130.86, 130.08, 130.03, 128.89, 127.79, 127.05, 126.91, 125.72, 125.25, 121.18, 116.96, 116.82, 115.40. HRMS (ESI) m/z calcd for C17H13N2S+ (M + H)+: 277.0794, found: 277.0795.

2-(2-Fluorophenyl)naphtho[2,1-d]thiazole (3s)13

Prepared according to the typical procedure as a yellow solid (47 mg, 84%). mp: 155–157 °C. 1H NMR (CDCl3, 500 MHz) δ 8.46 (td, J = 7.5 Hz, J = 1.5 Hz, 1H), 8.11 (d, J = 9.0 Hz, 1H), 8.07 (d, J = 8.0 Hz, 1H), 7.95 (d, J = 8.0 Hz, 1H), 7.87 (d, J = 9.0 Hz, 1H), 7.59 (td, J = 8.0 Hz, J = 1.0 Hz, 1H), 7.54 (td, J = 8.5 Hz, J = 1.5 Hz, 1H), 7.47–7.42 (m, 1H), 7.31 (td, J = 8.0 Hz, J = 1.0 Hz, 1H), 7.24–7.22 (m, 1H). 13C NMR (CDCl3, 125 MHz) δ 160.58 (d, J = 196.38 Hz), 159.60 (d, J = 61.25 Hz), 150.71, 133.03 (d, J = 8.13 Hz), 131.84 (d, J = 8.53 Hz), 131.05, 129.43 (d, J = 2.13 Hz), 128.96, 128.01, 127.48, 127.02, 126.13, 125.09, 124.72 (d, J = 3.38 Hz), 121.63, 121.48 (d, J = 10.88 Hz), 116.35 (d, J = 21.75). 19F NMR (CDCl3, 470 MHz) δ −111.91.

2-(2-Chlorophenyl)naphtho[2,1-d]thiazole (3t)10

Prepared according to the typical procedure as a white solid (48 mg, 81%). mp: 143–146 °C. 1H NMR (CDCl3, 500 MHz) δ 8.34 (d, J = 7.5 Hz ,1H), 8.14 (d, J = 9.0 Hz, 1H), 8.10 (d, J = 8.0 Hz, 1H), 7.97 (d, J = 8.0 Hz, 1H), 7.89 (d, J = 9.0 Hz, 1H), 7.61 (t, J = 7.0 Hz, 1H), 7.56 (t, J = 7.0 Hz, 2H), 7.45–7.39 (m, 2H). 13C NMR (CDCl3, 125 MHz) δ 162.79, 150.58, 133.40, 132.44, 132.15, 131.53, 131.08, 130.90, 130.80, 128.94, 127.92, 127.42, 127.12, 127.00, 126.15, 125.10, 121.70.

2-(2-Bromophenyl)naphtho[2,1-d]thiazole (3u)10

Prepared according to the typical procedure as a white solid (46 mg, 67%). mp: 136–139 °C. 1H NMR (CDCl3, 500 MHz) δ 8.15–8.12 (m, 2H), 8.08 (d, J = 8.0 Hz, 1H), 7.98 (d, J = 8.0 Hz, 1H), 7.90 (d, J = 8.5 Hz, 1H), 7.76 (dd, J = 8.0 Hz, J = 1.0 Hz, 1H), 7.61 (td, J = 8.0 Hz, J = 1.0 Hz, 1H), 7.56 (td, J = 8.0 Hz, J = 1.0 Hz, 1H), 7.46 (td, J = 7.5 Hz, J = 1.0 Hz, 1H), 7.33 (td, J = 8.0 Hz, J = 1.5 Hz, 1H). 13C NMR (CDCl3, 125 MHz) δ 164.27, 150.78, 134.34, 134.09, 133.44, 132.10, 131.09, 131.05, 128.94, 127.90, 127.59, 127.40, 127.00, 126.17, 125.14, 121.97, 121.77.

2-(3,5-Difluorophenyl)naphtho[2,1-d]thiazole (3v)

Prepared according to the typical procedure as a yellow solid (30 mg, 50%). mp: 149–151 °C. 1H NMR (CDCl3, 500 MHz) δ 8.05 (d, J = 8.5 Hz, 1H), 7.98 (d, J = 8.0 Hz, 1H), 7.95 (d, J = 8.0 Hz, 1H), 7.86 (d, J = 8.5 Hz, 1H), 7.63–7.54 (m, 4H), 6.91 (tt, J = 8.5 Hz, J = 2.5 Hz, 1H). 13C NMR (CDCl3, 125 MHz) δ 163.99 (t, J = 3.5 Hz), 163.20 (dd, J = 248.0 Hz, J = 12.6 Hz), 151.95, 136.52 (t, J = 9.8 Hz), 132.53, 131.20, 128.99, 127.83, 127.19, 126.39, 125.10, 121.68, 110.09 (dd, J = 20.6 Hz, J = 7.0 Hz), 105.72 (t, J = 25.3 Hz). 19F NMR (CDCl3, 470 MHz) δ −108.35. HRMS (ESI) m/z calcd for C17H10F2NS+ (M + H)+: 298.0497, found: 298.0495.

2-(2,4-Difluorophenyl)naphtho[2,1-d]thiazole (3w)

Prepared according to the typical procedure as a yellow solid (20 mg, 33%). mp: 153–156 °C. 1H NMR (CDCl3, 500 MHz) δ 8.50–8.46 (m, 1H), 8.11 (d, J = 9.0 Hz, 1H), 8.07 (d, J = 8.0 Hz, 1H), 7.97 (d, J = 8.0 Hz, 1H), 7.89 (d, J = 8.5 Hz, 1H), 7.62 (t, J = 7.5 Hz, 1H), 7.56 (d, J = 7.5 Hz, 1H), 7.08–7.05 (m, 1H), 7.03–6.99 (m, 1H). 13C NMR (CDCl3, 125 MHz) δ 164.00 (dd, J = 252.5 Hz, J = 11.6 Hz), 160.56 (dd, J = 253.9 Hz, J = 11.9 Hz), 158.91 (d, J = 6.6 Hz), 150.59, 132.72 (d, J = 7.9 Hz), 131.04, 130.77 (dd, J = 9.9 Hz, J = 4.0 Hz), 128.98, 127.95, 127.56, 127.07, 126.17, 125.02, 121.52, 118.09 (dd, J = 11.5 Hz, J = 3.8 Hz), 112.43 (dd, J = 21.5 Hz, J = 3.1 Hz), 104.62 (t, J = 25.5 Hz). 19F NMR (CDCl3, 470 MHz) δ −105.85 (d, J = 9.4 Hz), −107.85 (d, J = 9.4 Hz). HRMS (ESI) m/z calcd for C17H10F2NS+ (M + H)+: 298.0497, found: 298.0495.

2-(3,5-Dimethoxyphenyl)naphtho[2,1-d]thiazole (3x)

Prepared according to the typical procedure as a yellow solid (48 mg, 74%). mp: 140–142 °C. 1H NMR (CDCl3, 500 MHz) δ 8.10 (d, J = 9.0 Hz, 1H), 8.02 (d, J = 8.5 Hz, 1H), 7.95 (d, J = 8.0 Hz, 1H), 7.87 (d, J = 9.0 Hz, 1H), 7.60 (td, J = 7.0 Hz, J = 1.0 Hz, 1H), 7.54 (td, J = 8.0 Hz, J = 1.0 Hz, 1H), 7.31 (d, J = 2.5 Hz, 2H), 6.59 (t, J = 2.0 Hz, 1H), 3.91 (s, 6H). 13C NMR (CDCl3, 125 MHz) δ 167.03, 161.14, 151.99, 135.40, 132.20, 131.06, 128.95, 128.02, 127.41, 127.00, 126.02, 125.13, 121.65, 105.19, 103.24, 55.60. HRMS (ESI) m/z calcd for C19H16NO2S+ (M + H)+: 322.0896, found: 322.0898.

2-(3,5-Bis(trifluoromethyl)phenyl)naphtho[1,2-d]thiazole (3y)

Prepared according to the typical procedure as a yellow solid (32 mg, 39%). mp: 184–186 °C. 1H NMR (CDCl3, 500 MHz) δ 8.55 (s, 2H), 8.11 (d, J = 9.0 Hz, 1H), 8.03 (d, J = 8.0 Hz, 1H), 7.98–7.97 (m, 2H), 7.92 (d, J = 9.0 Hz, 1H), 7.63 (t, J = 7.0 Hz, 1H), 7.58 (t, J = 7.0 Hz, 1H). 13C NMR (CDCl3, 125 MHz) δ 163.01, 152.15, 135.67, 132.82, 132.61 (q, J = 33.5 Hz), 131.41, 129.10, 128.19, 127.88, 127.42, 127.04 (q, J = 3.4 Hz), 126.70, 125.19, 123.73 (q, J = 3.6 Hz), 123.02 (q, J = 271.3 Hz), 121.76. 19F NMR (CDCl3, 470 MHz) δ −62.94. HRMS (ESI) m/z calcd for C19H10F6NS+ (M + H)+: 398.0433, found: 398.0435.

2-Mesitylnaphtho[2,1-d]thiazole (3z)

Prepared according to the typical procedure as a colorless solid (37 mg, 63%). mp: 37–39 °C. 1H NMR (CDCl3, 500 MHz) δ 8.15 (d, J = 8.5 Hz, 1H), 8.05 (d, J = 8.0 Hz, 1H), 8.01 (d, J = 8.0 Hz, 1H), 7.91 (d, J = 9.0 Hz, 1H), 7.64–7.56 (m, 2H), 6.99 (s, 2H), 2.37 (s, 3H), 2.22 (s, 6H). 13C NMR (CDCl3, 125 MHz) δ 166.53, 151.44, 139.42, 137.36, 133.56, 133.33, 130.95, 130.64, 129.64, 128.96, 128.36, 128.06, 126.95, 125.98, 125.28, 121.86, 21.22, 20.18. HRMS (ESI) m/z calcd for C20H18NS+ (M + H)+: 304.1155, found: 304.1153.

2-(Pyridin-2-yl)naphtho[2,1-d]thiazole (3aa)13

Prepared according to the typical procedure as a yellow solid (17 mg, 32%). mp: 146–147 °C. 1H NMR (CDCl3, 500 MHz) δ 8.72 (d, J = 4.0 Hz, 1H), 8.41 (d, J = 8.0 Hz, 1H), 8.12 (t, J = 7.5 Hz, 2H), 7.98 (d, J = 8.0 Hz, 1H), 7.91–7.87 (m, 2H), 7.63 (t, J = 7.0 Hz, 1H), 7.58 (t, J = 7.0 Hz, 1H), 7.42–7.40 (m, 1H). 13C NMR (CDCl3, 125 MHz) δ 168.27, 152.38, 151.39, 149.68, 137.15, 133.72, 131.23, 128.96, 128.27, 127.55, 127.13, 126.34, 125.37, 125.10, 121.83, 120.48.

2-(Pyridin-3-yl)naphtho[2,1-d]thiazole (3ab)

Prepared according to the typical procedure as a yellow solid (32 mg, 62%). mp: 131–134 °C. 1H NMR (CDCl3, 500 MHz) δ 9.30 (d, J = 1.5 Hz, 1H), 8.69 (d, J = 4.0 Hz, 1H), 8.36 (d, J = 8.0 Hz, 1H), 8.06 (d, J = 9.0 Hz, 1H), 7.97 (d, J = 8.0 Hz, 1H), 7.93 (d, J = 8.0 Hz, 1H), 7.85 (d, J = 8.5 Hz, 1H), 7.58 (td, J = 8.0 Hz, J = 1.0 Hz, 1H), 7.53 (td, J = 8.0 Hz, J = 1.0 Hz, 1H), 7.40 (dd, J = 8.0 Hz, J = 4.5 Hz, 1H). 13C NMR (CDCl3, 125 MHz) δ 163.48, 152.15, 151.30, 148.35, 134.28, 132.39, 131.22, 129.79, 129.03, 127.95, 127.80, 127.22, 126.35, 125.21, 123.83, 121.67. HRMS (ESI) m/z calcd for C16H11N2S+ (M + H)+: 263.0638, found: 263.0637.

2-(Pyridin-4-yl)naphtho[2,1-d]thiazole (3ac)

Prepared according to the typical procedure as a brown solid (8 mg, 16%). mp: 140–143 °C. 1H NMR (CDCl3, 500 MHz) δ 8.78 (d, J = 5.5 Hz, 2H), 8.12 (d, J = 8.5 Hz, 1H), 8.06 (d, J = 7.5 Hz, 1H), 8.00–7.98 (m, 3H), 7.92 (d, J = 9.0 Hz, 1H), 7.64 (t, J = 7.0 Hz, 1H), 7.59 (td, J = 8.0 Hz, J = 1.0 Hz, 1H). 13C NMR (CDCl3, 125 MHz) δ 163.88, 152.21, 150.63, 140.59, 132.93, 131.38, 129.08, 128.05, 127.90, 127.33, 126.67, 125.27, 121.83, 120.96. HRMS (ESI) m/z calcd for C16H11N2S+ (M + H)+: 263.0638, found: 263.0637.

2-(Thiophen-2-yl)naphtho[2,1-d]thiazole (3ad)10

Prepared according to the typical procedure as a yellow solid (33 mg, 61%). mp: 122–125 °C. 1H NMR (CDCl3, 500 MHz) δ 8.06 (d, J = 9.0 Hz, 1H), 7.94 (t, J = 7.0 Hz, 2H), 7.85 (d, J = 9.0 Hz, 1H), 7.68 (d, J = 3.5 Hz, 1H), 7.58 (t, J = 7.0 Hz, 1H), 7.52 (t, J = 8.0 Hz, 1H), 7.49 (d, J = 5.0 Hz, 1H), 7.14 (t, J = 4.0 Hz, 1H). 13C NMR (CDCl3, 125 MHz) δ 160.56, 151.72, 137.37, 131.63, 131.03, 128.95, 128.87, 128.09, 128.04, 127.89, 127.47, 127.00, 125.93, 124.96, 121.43.

2-(Naphthalen-1-yl)naphtho[2,1-d]thiazole (3ae)13

Prepared according to the typical procedure as a yellow solid (49 mg, 80%). mp: 95–97 °C. 1H NMR (CDCl3, 500 MHz) δ 9.05 (d, J = 8.5 Hz, 1H), 8.24 (d, J = 8.5 Hz, 1H), 8.08 (d, J = 8.0 Hz, 1H), 8.01–7.99 (m, 3H), 7.96–7.93 (m, 2H), 7.68–7.65 (m, 1H), 7.64–7.57 (m, 4H). 13C NMR (CDCl3, 125 MHz) δ 166.61, 152.17, 133.99, 132.66, 131.01, 130.90, 130.81, 130.61, 129.35, 128.95, 128.38, 127.93, 127.59, 127.33, 126.98, 126.46, 126.03, 125.88, 125.34, 125.00, 121.91.

7-Bromo-2-phenylnaphtho[2,1-d]thiazole (3ba)

Prepared according to the typical procedure as a yellow solid (52 mg, 76%). mp: 170–172 °C. 1H NMR (CDCl3, 500 MHz) δ 8.11–8.08 (m, 4H), 7.85 (d, J = 8.5 Hz, 1H), 7.75 (d, J = 9.0 Hz, 1H), 7.65–7.63 (m, 1H), 7.51–7.50 (m, 3H). 13C NMR (CDCl3, 125 MHz) δ 167.52, 152.36, 133.40, 132.14, 131.01, 130.92, 130.17, 129.09, 127.31, 126.66, 126.51, 126.39, 122.75, 119.73. HRMS (ESI) m/z calcd for C17H11BrNS+ (M + H)+: 339.9790, found: 339.9791.

2-Methylnaphtho[2,1-d]thiazole (3ak)

Prepared according to the typical procedure as a bronzing liquid (11 mg, 28%). 1H NMR (CDCl3, 500 MHz) δ 8.00 (d, J = 8.5 Hz, 1H), 7.96 (d, J = 8.5 Hz, 2H), 7.85(d, J = 9.0 Hz, 1H), 7.58 (t, J = 7.5 Hz, 1H), 7.53 (t, J = 7.5 Hz, 1H), 2.92 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ 165.91, 151.25, 132.45, 130.82, 128.92, 128.02, 126.97, 126.88, 125.70, 125.03, 121.15, 20.13. HRMS (ESI) m/z calcd for C12H10NS+ (M + H)+: 200.0529, found: 200.0528.

2-Isopropylnaphtho[2,1-d]thiazole (3al)

Prepared according to the typical procedure as a yellow liquid (9 mg, 19%). 1H NMR (CDCl3, 500 MHz) δ 8.02 (d, J = 9.0 Hz, 1H), 7.98 (d, J = 8.5 Hz, 1H), 7.95 (d, J = 8.5 Hz, 1H), 7.85 (d, J = 9.0 Hz, 1H), 7.58 (td, J = 7.0 Hz, J = 1.0 Hz, 1H), 7.52 (td, J = 7.5 Hz, J = 1.0 Hz, 1H), 3.55–3.47 (m, 1H), 1.55 (s, 3H), 1.54 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ 177.74, 151.08, 131.55, 130.78, 128.92, 128.20, 126.89, 126.83, 125.63, 124.99, 121.37, 34.11, 23.13. HRMS (ESI) m/z calcd for C14H13NS+ (M + H)+: 227.0769, found: 227.0763.

5-Methoxy-2-phenylbenzo[d]thiazole (4a)13

Prepared according to the typical procedure as a yellow solid (23 mg, 42%). mp: 75–77 °C. 1H NMR (CDCl3, 500 MHz) δ 8.08–8.06 (m, 2H), 7.74 (d, J = 8.5 Hz, 1H), 7.58 (d, J = 2.5 Hz, 1H), 7.49–7.48 (m, 3H), 7.04 (dd, J = 9.0 Hz, J = 2.5 Hz, 1H), 3.91 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ 169.26, 159.09, 155.31, 133.65, 130.86, 128.97, 127.34, 126.83, 121.80, 115.84, 105.42, 55.57.

N,N-Dimethyl-2-phenylbenzo[d]thiazol-5-amine (4b)13

Prepared according to the typical procedure as a yellow solid (35 mg, 72%). mp: 87–90 °C. 1H NMR (CDCl3, 500 MHz) δ 8.09–8.07 (m, 2H), 7.70 (d, J = 9.0 Hz, 1H), 7.48–7.47 (m, 3H), 7.40 (d, J = 2.0 Hz, 1H), 7.93 (dd, J = 9.0 Hz, J = 2.5 Hz, 1H), 3.03 (s, 6H). 13C NMR (CDCl3, 125 MHz) δ 168.53, 155.74, 150.16, 133.88, 130.59, 128.87, 127.26, 123.12, 121.41, 113.13, 105.63, 41.07.

N-(2-Phenylbenzo[d]thiazol-5-yl)acetamide (4c)

Prepared according to the typical procedure as a yellow solid (29 mg, 55%). mp: 184–186 °C. 1H NMR (CDCl3, 500 MHz) δ 8.17 (d, J = 1.5 Hz, 1H), 8.06–8.04 (m, 2H), 7.80 (d, J = 9.0 Hz, 1H), 7.76 (s, 1H), 7.64 (dd, J = 8.5 Hz, J = 2.0 Hz, 1H), 7.49–7.48 (m, 3H), 2.22 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ 169.31, 168.58, 154.52, 136.70, 133.41, 131.05, 130.57, 129.01, 127.47, 121.70, 118.46, 113.89, 24.61. HRMS (ESI) m/z calcd for C15H13N2OS+ (M + H)+: 269.0743, found: 269.0744.

5-(Benzyloxy)-2-phenylbenzo[d]thiazole (4d)

Prepared according to the typical procedure as a white solid (36 mg, 60%). mp: 124–125 °C. 1H NMR (CDCl3, 500 MHz) δ 8.08–8.06 (m, 2H), 7.76 (d, J = 9.0 Hz, 1H), 7.65 (d, J = 2.5 Hz, 1H), 7.50–7.49 (m, 5H), 7.42 (t, J = 7.5 Hz, 2H), 7.35 (t, J = 7.5 Hz, 1H), 7.13 (dd, J = 8.5 Hz, J = 2.5 Hz, 1H), 5.18 (s, 2H). 13C NMR (CDCl3, 125 MHz) δ 169.29, 158.16, 155.21, 136.63, 133.60, 130.89, 128.99, 128.61, 128.05, 127.53, 127.35, 127.11, 121.88, 116.10, 106.63, 70.33. HRMS (ESI) m/z calcd for C20H17N2S+ (M + H)+: 317.1107, found: 317.1107.

5,7-Dimethoxy-2-phenylbenzo[d]thiazole (4e)13

Prepared according to the typical procedure as a yellow solid (47 mg, 84%). mp: 84–85 °C. 1H NMR (CDCl3, 500 MHz) δ 8.08–8.07 (m, 2H), 7.49–7.47(m, 3H), 7.20 (d, J = 2.0 Hz, 1H), 6.50 (d, J = 2.0 Hz, 1H), 3.96 (s, 3H), 3.90 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ 169.24, 160.35, 155.74, 154.30, 133.66, 130.79, 128.97, 127.29, 116.21, 97.50, 96.90, 55.90, 55.74.

5-Methoxy-7-methyl-2-phenylbenzo[d]thiazole (4f)

Prepared according to the typical procedure as a white solid (47 mg, 93%). mp: 83–85 °C. 1H NMR (CDCl3, 500 MHz) δ 8.09–8.07 (m, 2H), 7.51–7.48 (m, 3H), 7.42 (d, J = 2.0 Hz, 1H), 6.85 (d, J = 1.0 Hz, 1H), 3.88 (s, 3H), 2.54 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ 168.47, 159.21, 154.80, 133.74, 132.08, 130.74, 128.94, 127.63, 127.25, 115.54, 102.80, 55.52, 21.41. HRMS (ESI) m/z calcd for C15H14NOS+ (M + H)+: 256.0791, found: 256.0790.

5,6-Dimethoxy-2-phenylbenzo[d]thiazole (4g)10

Prepared according to the typical procedure as a yellow solid (48 mg, 88%). mp: 143–147 °C. 1H NMR (CDCl3, 500 MHz) δ 8.02–8.01 (m, 2H), 7.54 (s, 1H), 7.48–7.42 (m, 3H), 7.28 (s, 1H), 3.97 (s, 3H), 3.95 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ 166.16, 149.31, 148.45, 148.34, 133.68, 130.35, 128.91, 126.92, 104.53, 102.26, 56.21, 56.03.

5,6,7-Trimethoxy-2-phenylbenzo[d]thiazole (4h)10

Prepared according to the typical procedure as a yellow solid (28 mg, 46%). mp: 56–60 °C. 1H NMR (CDCl3, 500 MHz) δ 8.05–8.03 (m, 2H), 7.50–7.46 (m, 3H), 7.36 (s, 1H), 4.10 (s, 3H), 3.95 (s, 3H), 3.94 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ 167.92, 153.92, 150.41, 146.68, 139.68, 133.51, 130.69, 128.96, 127.14, 120.20, 100.62, 61.44, 60.52, 56.21.

5,6,7-Trimethyl-2-phenyl-6,7-dihydrobenzo[d]thiazole (4i)

Prepared according to the typical procedure as a yellow solid (35 mg, 67%). mp: 74–76 °C. 1H NMR (CDCl3, 500 MHz) δ 8.09–8.07 (m, 2H), 7.75 (s, 1H), 7.50–7.47 (m, 3H), 2.54 (s, 3H), 2.43 (s, 3H), 2.31 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ 166.47, 151.56, 135.76, 134.17, 133.89, 132.22, 130.52, 128.89, 128.83, 127.28, 121.35, 21.32, 20.12, 15.62. HRMS (ESI) m/z calcd for C16H16NS+ (M + H)+: 254.0998, found: 254.0996.

Acknowledgments

G.D., Y.L., and Y.Y. received funding from the National Natural Science Foundation of China (nos. 21602057, 21572051, 21901071, and 21971061), the Opening Fund of the Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education of China), and Hunan Normal University (nos. KLCBTCMR201707 and KLCBTCMR201708), Y.L., Y.Y., and X.Z received funding from the Scientific Research Projects of Education Department of Hunan Province (nos. 18A002, 18K089, and 19B359). Y.L. received funding from the Science and Technology Planning Project of Hunan Province (no. 2018TP1017). X.Z. received funding from Hengyang Normal University (no. 19QD14).

Supporting Information Available

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsomega.0c01150.

  • 1H NMR and 13C{1H} NMR spectra of product (PDF)

The authors declare no competing financial interest.

Supplementary Material

ao0c01150_si_001.pdf (4.4MB, pdf)

References

  1. a Fontana G. Current Bioactive Azole-containing Natural Products. Curr. Bioact. Compd. 2010, 6, 284–308. 10.2174/157340710793237290. [DOI] [Google Scholar]; b Geng J.; Li M.; Wu L.; Ren J.; Qu X. Liberation of Copper from Amyloid Plaques: Making a Risk Factor Useful for Alzheimer’s Disease Treatment. J. Med. Chem. 2012, 55, 9146–9155. 10.1021/jm3003813. [DOI] [PubMed] [Google Scholar]
  2. a Mortimer C. G.; Wells G.; Crochard J.-P.; Stone E. L.; Bradshaw T. D.; Stevens M. F. G.; Westwell A. D. Antitumor Benzothiazoles. 26. 2-(3,4-Dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a Simple Fluorinated 2-Arylbenzothiazole, Shows Potent and Selective Inhibitory Activity Against Lung, Colon, and Breast Cancer Cell Lines. J. Med. Chem. 2006, 49, 179–185. 10.1021/jm050942k. [DOI] [PubMed] [Google Scholar]; b Serdons K.; Terwinghe C.; Vermaelen P.; van Laere K.; Kung H.; Mortelmans L.; Bormans G.; Verbruggen A. Synthesis and Evaluation of 18F-labeled 2-Phenylbenzothiazoles as Positron Emission Tomography Imaging Agents for Amyloid Plaques in Alzheimer’s Disease. J. Med. Chem. 2009, 52, 1428–1437. 10.1021/jm8013376. [DOI] [PubMed] [Google Scholar]; c Hrobáriková V.; Hrobárik P.; Gajdoš P.; Fitilis I.; Fakis M.; Persephonis P.; Zahradník P. Benzothiazole-based Fluorophores of Donor-π-acceptor-π-donor Type Displaying High Two-photon Absorption. J. Org. Chem. 2010, 75, 3053–3068. 10.1021/jo100359q. [DOI] [PubMed] [Google Scholar]; d Chakraborty M.; Jin K. J.; Glover S. A.; Novak M. Characterization of the 4-(Benzothiazol-2-yl)phenylnitrenium Ion from a Putative Metabolite of a Model Antitumor Drug. J. Org. Chem. 2010, 75, 5296–5304. 10.1021/jo101275y. [DOI] [PMC free article] [PubMed] [Google Scholar]; e Sun Q.; Wu R.; Cai S.; Lin Y.; Sellers L.; Sakamoto K.; He B.; Peterson B. R. Synthesis and Biological Evaluation of Analogues of AKT (Protein Kinase B) Inhibitor-IV. J. Med. Chem. 2011, 54, 1126–1139. 10.1021/jm100912b. [DOI] [PMC free article] [PubMed] [Google Scholar]; f Facchinetti V.; da R Reis R.; Gomes C. R. B.; Vasconcelos T. R. A. Chemistry and Biological Activities of 1,3-Benzothiazoles. Mini-Rev. Org. Chem. 2012, 9, 44–53. 10.2174/157019312799079929. [DOI] [Google Scholar]; g Noël S.; Cadet S.; Gras E.; Hureau C. The Benzazole Scaffold: a SWAT to Combat Alzheimer’s Disease. Chem. Soc. Rev. 2013, 42, 7747–7762. 10.1039/c3cs60086f. [DOI] [PubMed] [Google Scholar]
  3. a Itoh T.; Mase T. A Novel Practical Synthesis of Benzothiazoles via Pd-catalyzed Thiol Cross-coupling. Org. Lett. 2007, 9, 3687–3689. 10.1021/ol7015737. [DOI] [PubMed] [Google Scholar]; b Hachiya H.; Hirano K.; Satoh T.; Miura M. Nickel-catalyzed Direct C-H Arylation and Alkenylation of Heteroarenes with Organosilicon Reagents. Angew. Chem., Int. Ed. 2010, 49, 2202–2205. 10.1002/anie.200906996. [DOI] [PubMed] [Google Scholar]; c Jiang H.; Yu W.; Tang X.; Li J.; Wu W. Copper-catalyzed Aerobic Oxidative Regioselective Thiocyanation of Aromatics and Heteroaromatics. J. Org. Chem. 2017, 82, 9312–9320. 10.1021/acs.joc.7b01122. [DOI] [PubMed] [Google Scholar]; d Liu L.; Tan C.; Fan R.; Wang Z.; Du H.; Xu K.; Tan J. I2/TBHP-mediated Tandem Cyclization and Oxidation Reaction: Facile Access to 2-Substituted Thiazoles and Benzothiazoles. Org. Biomol. Chem. 2019, 17, 252–256. 10.1039/C8OB02826E. [DOI] [PubMed] [Google Scholar]; e Kumar D.; Mishra B. B.; Tiwari V. K. Synthesis of 2-N/S/C-Substituted Benzothiazoles via Intramolecular Cyclative Cleavage of Benzotriazole Ring. J. Org. Chem. 2014, 79, 251–266. 10.1021/jo4024107. [DOI] [PubMed] [Google Scholar]; f Khatun N.; Guin S.; Rout S. K.; Patel B. K. Divergent Reactivities of o-Haloanilides with CuO Nanoparticles in Water: a Green Synthesis of Benzoxazoles and o-Hydroxyanilides. RSC Adv. 2014, 4, 10770–10778. 10.1039/c3ra46820h. [DOI] [Google Scholar]; g Sahoo S. K.; Khatun N.; Gogoi A.; Deb A.; Patel B. K. Cu(II) Catalysed Chemoselective Oxidative Transformation of Thiourea to Thioamidoguanidine/2-aminobenzothiazole. RSC Adv. 2013, 3, 438–446. 10.1039/C2RA22240J. [DOI] [Google Scholar]; h Kumar D.; Mishra A.; Mishra B. B.; Bhattacharya S.; Tiwari V. K. Synthesis of Glycoconjugate Benzothiazoles via Cleavage of Benzotriazole Ring. J. Org. Chem. 2013, 78, 899–909. 10.1021/jo3021049. [DOI] [PubMed] [Google Scholar]; i Banerjee A.; Santra S. K.; Rout S. K.; Patel B. K. A Ligand Free Copper(II) Catalyst is as Effective as a Ligand Assisted Pd(II) Catalyst towards Intramolecular Ce-S Bond Formation via C-H Functionalization. Tetrahedron 2013, 69, 9096–9104. 10.1016/j.tet.2013.08.025. [DOI] [Google Scholar]; j Singh A. S.; Mishra N.; Yadav M. S.; Tiwari V. K. Free Radical Synthetic Protocol for Benzothiazoles via Ring Opening of Benzotriazole: A Two-step Organic Chemistry Experiment for Undergraduate and Postgraduate Students. J. Heterocyclic Chem. 2019, 56, 275–280. 10.1002/jhet.3405. [DOI] [Google Scholar]; k Kumar D.; Singh A. S.; Tiwari V. K. An Improved Synthetic Protocol for Benzothiazoles via Ring Opening of Benzotriazole. ChemistrySelect 2018, 3, 7809–7812. 10.1002/slct.201801241. [DOI] [Google Scholar]
  4. a Inamoto K.; Hasegawa C.; Hiroya K.; Doi T. Palladium-catalyzed Synthesis of 2-Substituted Benzothiazoles via a C-H Functionalization/intramolecular C-S Bond Formation Process. Org. Lett. 2008, 10, 5147–5150. 10.1021/ol802033p. [DOI] [PubMed] [Google Scholar]; b Cheng Y.; Yang J.; Qu Y.; Li P. Aerobic Visible-light Photoredox Radical C-H Functionalization: Catalytic Synthesis of 2-Substituted Benzothiazoles. Org. Lett. 2012, 14, 98–101. 10.1021/ol2028866. [DOI] [PubMed] [Google Scholar]; c Wang H.; Wang L.; Shang J.; Li X.; Wang H.; Gui J.; Lei A. Fe-catalysed Oxidative C-H Functionalization/C-S Bond Formation. Chem. Commun. 2012, 48, 76–78. 10.1039/C1CC16184A. [DOI] [PubMed] [Google Scholar]; d Zhang G.; Liu C.; Yi H.; Meng Q.; Bian C.; Chen H.; Jian J.-X.; Wu L.-Z.; Lei A. External Oxidant-free Oxidative Cross-coupling: a Photoredox Cobalt-catalyzed Aromatic C-H Thiolation for Constructing C-S bonds. J. Am. Chem. Soc. 2015, 137, 9273–9280. 10.1021/jacs.5b05665. [DOI] [PubMed] [Google Scholar]; e Qian X.-Y.; Li S.-Q.; Song J.; Xu H.-C. TEMPO-catalyzed Electrochemical C-H Thiolation: Synthesis of Benzothiazoles and Thiazolopyridines from Thioamides. ACS Catal. 2017, 7, 2730–2734. 10.1021/acscatal.7b00426. [DOI] [Google Scholar]; f Wang P.; Tang S.; Lei A. Electrochemical Intramolecular Dehydrogenative C-S Bond Formation for the Synthesis of Benzothiazoles. Green Chem. 2017, 19, 2092–2095. 10.1039/C7GC00468K. [DOI] [Google Scholar]; g Xu Z.-M.; Li H.-X.; Young D. J.; Zhu D.-L.; Li H.-Y.; Lang J.-P. Exogenous Photosensitizer-, Metal-, and Base-free Visible-light-promoted C-H Thiolation via Reverse Hydrogen Atom Transfer. Org. Lett. 2019, 21, 237–241. 10.1021/acs.orglett.8b03679. [DOI] [PubMed] [Google Scholar]; h Bouchet L. M.; Heredia A. A.; Argüello J. E.; Schmidt L. C. Riboflavin as Photoredox Catalyst in the Cyclization of Thiobenzanilides: Synthesis of 2-Substituted Benzothiazoles. Org. Lett. 2020, 22, 610–614. 10.1021/acs.orglett.9b04384. [DOI] [PubMed] [Google Scholar]; i Sahoo S. K.; Banerjee A.; Chakraborty S.; Patel B. K. Regioselective Intramolecular Arylthiolations by Ligand Free Cu and Pd Catalyzed Reaction. ACS Catal. 2012, 2, 544–551. 10.1021/cs200590p. [DOI] [Google Scholar]; j Khatun N.; Jamir L.; Ganesh L.; Patel B. K. A One-pot Strategy for the Synthesis of 2-Aminobenzothiazole in Water by Copper Catalysis. RSC Adv. 2012, 2, 11557–11565. 10.1039/c2ra21826g. [DOI] [Google Scholar]
  5. a Raghavendra G. M.; Ramesha A. B.; Revanna C. N.; Nandeesh K. N.; Mantelingu K.; Rangappa K. S. One-pot Tandem Approach for the Synthesis of Benzimidazoles and Benzothiazoles from Alcohols. Tetrahedron Lett. 2011, 52, 5571–5574. 10.1016/j.tetlet.2011.08.037. [DOI] [Google Scholar]; b Liao Y.; Qi H.; Chen S.; Jiang P.; Zhou W.; Deng G.-J. Efficient 2-Aryl Benzothiazole Formation from Aryl Ketones and 2-Aminobenzenethiols under Metal-free Conditions. Org. Lett. 2012, 14, 6004–6007. 10.1021/ol302902e. [DOI] [PubMed] [Google Scholar]; c Wen X.; Bakali J. E.; Deprez-Poulain R.; Deprez B. Efficient Propylphosphonic Anhydride (T3P) Mediated Synthesis of Benzothiazoles, Benzoxazoles and Benzimidazoles. Tetrahedron Lett. 2012, 53, 2440–2443. 10.1016/j.tetlet.2012.03.007. [DOI] [Google Scholar]; d Sun Y.; Jiang H.; Wu W.; Zeng W.; Wu X. Copper-catalyzed Synthesis of Substituted Benzothiazoles via Condensation of 2-Aminobenzenethiols with Nitriles. Org. Lett. 2013, 15, 1598–1601. 10.1021/ol400379z. [DOI] [PubMed] [Google Scholar]; e Wade A. R.; Pawar H. R.; Biware M. V.; Chikate R. C. Synergism in Semiconducting Nanocomposite: Visible Light Photocatalysis towards Formation of C-S and C-N Bonds. Green Chem. 2015, 17, 3879–3888. 10.1039/C5GC00748H. [DOI] [Google Scholar]
  6. a Hou C.; Ren Y.; Lang R.; Hu X.; Xia C.; Li F. Palladium-catalyzed Direct Phosphonation of Azoles with Dialkyl Phosphites. Chem. Commun. 2012, 48, 5181–5183. 10.1039/c2cc30429e. [DOI] [PubMed] [Google Scholar]; b Gao Y.; Song Q.; Cheng G.; Cui X. KI-catalyzed Arylation of Benzothiazoles from the Coupling of Aryl Aldehydes with Benzothiazoles in Neat Water. Org. Biomol. Chem. 2014, 12, 1044–1047. 10.1039/C3OB42318B. [DOI] [PubMed] [Google Scholar]; c Arora A.; Weaver J. D. Photocatalytic Generation of 2-Azolyl Radicals: Intermediates for the Azolylation of Arenes and Heteroarenes via C-H Functionalization. Org. Lett. 2016, 18, 3996–3999. 10.1021/acs.orglett.6b01718. [DOI] [PubMed] [Google Scholar]; d Dai X.; Zhu Y.; Wang Z.; Weng J. Progress in 2-Position Functionalized Synthesis of 2-Substituted Benzothiazoles. Chin. J. Org. Chem. 2017, 37, 1924–1938. 10.6023/cjoc201703034. [DOI] [Google Scholar]; e Huang T.; Wu X.; Yu Y.; An L.; Yin X. A Convenient Synthesis of 2-Acyl Benzothiazoles/thiazoles from Benzothiazole/thiazole and N, N’-Carbonyldiimidazole Activated Carboxylic Acids. Tetrahedron Lett. 2019, 60, 1667–1670. 10.1016/j.tetlet.2019.05.043. [DOI] [Google Scholar]
  7. a Li G.; Xie H.; Chen J.; Guo Y.; Deng G.-J. Three-component Synthesis of 2-Heteroaryl-benzothiazoles under Metal-free Conditions. Green Chem. 2017, 19, 4043–4047. 10.1039/C7GC01932G. [DOI] [Google Scholar]; b Xing Q.; Ma Y.; Xie H.; Xiao F.; Zhang F.; Deng G.-J. Iron-promoted Three-component 2-Substituted Benzothiazole Formation via Nitroarene ortho-C-H Sulfuration with Elemental Sulfur. J. Org. Chem. 2018, 84, 1238–1246. 10.1021/acs.joc.8b02619. [DOI] [PubMed] [Google Scholar]; c Xu Z.; Huang H.; Chen H.; Deng G.-J. Catalyst- and Additive-free Annulation/aromatization Leading to Benzothiazoles and Naphthothiazoles. Org. Chem. Front. 2019, 6, 3060–3064. 10.1039/C9QO00592G. [DOI] [Google Scholar]; d Dey A.; Hajra A. Metal-free Synthesis of 2-Arylbenzothiazoles from Aldehydes, Amines, and Thiocyanate. Org. Lett. 2019, 21, 1686–1689. 10.1021/acs.orglett.9b00245. [DOI] [PubMed] [Google Scholar]; e Zhou P.; Huang Y.; Wu W.; Zhou J.; Yu W.; Jiang H. Access to 2-Aroylthienothiazoles via C-H/N-O Bond Functionalization of Oximes. Org. Lett. 2019, 21, 9976–9980. 10.1021/acs.orglett.9b03900. [DOI] [PubMed] [Google Scholar]; f Zhou P.; Huang Y.; Wu W.; Yu J.; Li J.; Zhu Z.; Jiang H. Direct Access to bis-S-heterocycles via Copper-catalyzed Three Component Tandem Cyclization Using S8 as a Sulfur Source. Org. Biomol. Chem. 2019, 17, 3424–3432. 10.1039/C9OB00377K. [DOI] [PubMed] [Google Scholar]; g Huang H.; Xu Z.; Ji X.; Li B.; Deng G.-J. Thiophene-fused Heteroaromatic Systems Enabled by Internal Oxidant-induced Cascade Bis-heteroannulation. Org. Lett. 2018, 20, 4917–4920. 10.1021/acs.orglett.8b02049. [DOI] [PubMed] [Google Scholar]; h Huang H.; Wang Q.; Xu Z.; Deng G.-J. Tri-functional Elemental Sulfur Enabling Bis-heteroannulation of Methyl Ketoximes with Methyl N-Heteroarenes. Adv. Synth. Catal. 2019, 361, 591–596. 10.1002/adsc.201801324. [DOI] [Google Scholar]; i Huang H.; Qu Z.; Ji X.; Deng G.-J. Three-component Bis-heterocycliation for Synthesis of 2-Aminobenzo[4,5]thieno[3,2-d]thiazoles. Org. Chem. Front. 2019, 6, 1146–1150. 10.1039/C8QO01365A. [DOI] [Google Scholar]
  8. a Deng H.; Li Z.; Ke F.; Zhou X. Cu-catalyzed Three-component Synthesis of Substituted Benzothiazoles in Water. Chem. – Eur. J. 2012, 18, 4840–4843. 10.1002/chem.201103525. [DOI] [PubMed] [Google Scholar]; b Yang Z.; Hu R.; Li X.; Wang X.; Gu R.; Han S. One-pot Copper-catalyzed Synthesis of 2-Substituted Benzothiazoles from 2-Iodoanilines, Benzyl Chlorides and Elemental Sulfur. Tetrahedron Lett. 2017, 58, 2366–2369. 10.1016/j.tetlet.2017.05.004. [DOI] [Google Scholar]; c Wang X.; Li X.; Hu R.; Yang Z.; Gu R.; Ding S.; Li P.; Han S. Elemental Sulfur-mediated Decarboxylative Redox Cyclization Reaction: Copper-catalyzed Synthesis of 2-Substituted Benzothiazoles. Synlett 2018, 29, 219–224. 10.1055/s-0036-1589112. [DOI] [Google Scholar]; d Huang Y.; Zhou P.; Wu W.; Jiang H. Selective Construction of 2-Substituted Benzothiazoles from o-Iodoaniline Derivatives S8 and N-Tosylhydrazones. J. Org. Chem. 2018, 83, 2460–2466. 10.1021/acs.joc.7b03118. [DOI] [PubMed] [Google Scholar]; e Huang Y.; Yan D.; Wang X.; Zhou P.; Wu W.; Jiang H. Controllable Assembly of the Benzothiazole Framework Using a C≡C Triple Bond as a One-carbon Synthon. Chem. Commun. 2018, 54, 1742–1745. 10.1039/C7CC09855C. [DOI] [PubMed] [Google Scholar]
  9. a Tong Y.; Pan Q.; Jiang Z.; Miao D.; Shi X.; Han S. A Simple Approach to Benzothiazoles from 2-Chloronitrobenzene, Elemental Sulfur, and Aliphatic Amine under Solvent-free and Catalyst-free Conditions. Tetrahedron Lett. 2014, 55, 5499–5503. 10.1016/j.tetlet.2014.08.037. [DOI] [Google Scholar]; b Guntreddi T.; Vanjari R.; Singh K. N. Elemental Sulfur Mediated Decarboxylative Redox Cyclization Reaction of o-Chloronitroarenes and Arylacetic Acids. Org. Lett. 2015, 17, 976–978. 10.1021/acs.orglett.5b00079. [DOI] [PubMed] [Google Scholar]; c Wang X.; Miao D.; Li X.; Hu R.; Yang Z.; Gu R.; Han S. Elemental Sulfur Mediated Cyclization via Redox Strategy: Synthesis of Benzothiazoles from o-Chloronitrobenzenes and Benzyl Chlorides. Tetrahedron 2017, 73, 5194–5199. 10.1016/j.tet.2017.07.013. [DOI] [Google Scholar]
  10. Che X.; Jiang J.; Xiao F.; Huang H.; Deng G.-J. Assembly of 2-Arylbenzothiazoles through Three-component Oxidative Annulation under Transition-metal-free Conditions. Org. Lett. 2017, 19, 4576–4579. 10.1021/acs.orglett.7b02168. [DOI] [PubMed] [Google Scholar]
  11. Jiang J.; Li G.; Zhang F.; Xie H.; Deng G.-J. Aniline ortho C-H Sulfuration/cyclization with Elemental Sulfur for Efficient Synthesis of 2-Substituted Benzothiazoles under Metal-free Conditions. Adv. Synth. Catal. 2018, 360, 1622–1627. 10.1002/adsc.201701560. [DOI] [Google Scholar]
  12. Liu Y.; Yuan X.; Guo X.; Zhang X.; Chen B. Efficient 2-Aryl Benzothiazole Formation from Acetophenones, Anilines, and Elemental Sulfur by Iodine-catalyzed Oxidative C(CO)-C(alkyl) Bond Cleavage. Tetrahedron 2018, 74, 6057–6062. 10.1016/j.tet.2018.08.047. [DOI] [Google Scholar]
  13. a Zhang X.; Zeng W.; Yang Y.; Huang H.; Liang Y. Copper-catalyzed Double C-S Bonds Formation via Different Paths: Synthesis of Benzothiazoles from N-Benzyl-2-iodoaniline and Potassium Sulfide. Org. Lett. 2014, 16, 876–879. 10.1021/ol403638d. [DOI] [PubMed] [Google Scholar]; b Min H.; Xiao G.; Liu W.; Liang Y. Copper-catalyzed Synthesis of 2-Aminobenzothiazoles from 2-Iodophenyl Isocyanides, Potassium Sulfide and Amines. Org. Biomol. Chem. 2016, 14, 11088–11091. 10.1039/C6OB02413K. [DOI] [PubMed] [Google Scholar]; c Zhu X.; Yang Y.; Xiao G.; Song J.; Liang Y.; Deng G. Double C-S Bond Formation via C-H Bond Functionalization: Synthesis of Benzothiazoles and Naphtho[2,1-d]thiazoles from N-Substituted Arylamines and Elemental Sulfur. Chem. Commun. 2017, 53, 11917–11920. 10.1039/C7CC07366F. [DOI] [PubMed] [Google Scholar]
  14. a Su F.; Mathew S. C.; Möhlmann L.; Antonietti M.; Wang X.; Blechert S. Aerobic Oxidative Coupling of Amines by Carbon Nitride Photocatalysis with Visible Light. Angew. Chem., Int. Ed. 2011, 50, 657–660. 10.1002/anie.201004365. [DOI] [PubMed] [Google Scholar]; b Nguyen T. B.; Ermolenko L.; Al-Mourabit A. Efficient and Selective Multicomponent Oxidative Coupling of Two Different Aliphatic Primary Amines into Thioamides by Elemental Sulfur. Org. Lett. 2012, 14, 4274–4277. 10.1021/ol3020368. [DOI] [PubMed] [Google Scholar]; c Xu H.; Luo C.; Li Z.; Xiang H.; Zhou X. Synthesis of 2-Arylbenzothiazoles by Copper-catalyzed One-pot Three-component Reactions in Water. J. Heterocyclic Chem. 2016, 53, 1207–1213. 10.1002/jhet.2385. [DOI] [Google Scholar]; d Sheng J.; Liu J.; Zhao H.; Zheng L.; Wei X. Metal-free Synthesis of Imidazo[1,5-a]pyridines via Elemental Sulfur Mediated Sequential dual Oxidative Csp3-H Amination. Org. Biomol. Chem. 2018, 16, 5570–5574. 10.1039/C8OB01391H. [DOI] [PubMed] [Google Scholar]; e Pramanik M.; Choudhuri K.; Chakraborty S.; Ghosh A.; Mal P. (Z)-Selective anti-Markovnikov or Markovnikov Thiol-Yne-Click Reactions of an Internal Alkyne by Amide Hydrogen Bond Control. Chem. Commun. 2020, 56, 2991–2994. 10.1039/D0CC00702A. [DOI] [PubMed] [Google Scholar]; f Majji G.; Rajamanickam S.; Khatun N.; Santra S. K.; Patel B. K. Generation of Bis-acyl Ketals from Esters and Benzyl Amines Under Oxidative Conditions. J. Org. Chem. 2015, 80, 3440–3446. 10.1021/jo502903d. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

ao0c01150_si_001.pdf (4.4MB, pdf)

Articles from ACS Omega are provided here courtesy of American Chemical Society

RESOURCES